Central Nervous System Germ Cell Tumor
📧 Sign up to get email alerts when something new happens for Central Nervous System Germ Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) [Phase 2]
Phase 2 results for the GemPOx regimen (gemcitabine, paclitaxel, and oxaliplatin) in central nervous system germ cell tumors; results have b…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors [Phase 1]
Phase 1 study of AZD2171 (cediranib) in children with recurrent, progressive, or refractory primary central nervous system tumors has comple…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or peripheral stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating multimodal therapy for primary central nervous system germ cell tumors. The treatment approaches include c…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor [Phase 3]
A Phase 3 trial comparing radiation therapy to chemotherapy plus radiation therapy in newly diagnosed primary CNS germ cell tumors; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [Phase 1]
A Phase 1 clinical trial evaluated lenalidomide in young patients with recurrent, progressive, or refractory central nervous system tumors. …
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Irinotecan in Treating Children With Refractory Solid Tumors [Phase 2]
A Phase 2 trial evaluating irinotecan in children with refractory solid tumors has completed, with results reported by the Children's Oncolo…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia [Phase 1]
Phase 1 trial evaluating FR901228 in pediatric patients with refractory or recurrent solid tumors or leukemia has completed.